@article {Cardoso2020.06.08.20122531, author = {Liziane Cardoso and Tatyana Nery and Maielen Gon{\c c}alves and Maria Carolina Speck and Ana Cristina de Bem Alves and Viviane Bristot and Thais Gon{\c c}alves and D{\'e}bora da Luz Scheffer and Ione Jayce Ceola Schneider and Heloyse Kuriki and Aderbal S Aguiar, Junior}, title = {Caffeine decreases neuromuscular fatigue in the lumbar muscles {\textendash} a randomized blind study}, elocation-id = {2020.06.08.20122531}, year = {2020}, doi = {10.1101/2020.06.08.20122531}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Ergogenic evidence for caffeine is robust in sports and isolated limb tasks. Our objective was to evaluate a possible ergogenic effect on postural muscles, still unknown, through the Biering-S{\o}rensen{\textquoteright}s lumbar extension test.Methods A double-blind, controlled placebo, crossover study. Fifty-one healthy, physically inactive male subjects (18-25 years) with average body mass (BMI 18.5 {\textendash} 24.9 kg/m2) were recruited. The subjects received oral caffeine (6 mg/kg) and saline (0.3\%) in two cross-evaluations separated by one week. The primary outcome was the time in the Biering-S{\o}rensen test after 1 hour of treatment. The secondary outcomes were peak lumbar extension force, rating of perceived exertion, EMG{\textquoteright}s median frequency and muscle recruitment of multifidus spinae and transversalis/interne oblique muscles, and cardiovascular variables (heart rate and blood pressure).Results 27 subjects were blindly treated with caffeine and saline. Caffeine was ergogenic during the Biering-S{\o}rensen test. It increased lumbar extension time (d = 0.34, P\<0.05), but not peak force. The perception of effort decreased with caffeine (d = 0.37, P\<0.05). Caffeine increased muscle stimulation frequency (P\<0.05) and recruitment (η2 = 0.49, P\<0.05) of multifidus spinae. In the transversalis/interne oblique muscles, caffeine increased the median frequency η2 = 0.13, P\<0.05) and the distribution of higher frequencies (P\<0.05). Caffeine also increased muscle recruitment in the transversalis/interne oblique muscles η2 = 0.13, P\<0.05) Tachycardia and increased blood pressure at the lumbar test were higher in the caffeine condition (P\< 0.05).Conclusions Our results show that caffeine is ergogenic for postural muscles. Decreased RPE and improved muscle activity suggest central mechanisms of caffeine.Trial registration UTN U1111-1234-2079.BULLET POINTSCaffeine increases the extension time of the lumbar spine in the Biering-S{\o}rensen test.Caffeine decreases perceived exertion during the Biering-S{\o}rensen test.Caffeine increases muscle stimulation and recruitment of the multifidus spinae during the Biering-S{\o}rensen test.Caffeine increases muscle stimulation of the transversalis/interne oblique muscles during the Biering-S{\o}rensen test.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialUTN U1111-1234-2079Clinical Protocols http://www.ensaiosclinicos.gov.br/rg/?q=RBR-39JNP4 Funding StatementThis study was financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 1, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The trial was approved by the Brazilian Ethics Committee (http://plataformabrasil.saude.gov.br) with file number CAEE 86400418.0.0000.0121 and was prospectively registered (trial RBR-39JNP4) in the Brazilian Clinical Trials Register (http://www.ensaiosclinicos.gov.br/). The Universal Trial Number (UTN) is U1111-1234-2079.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymous data will be available beginning three months and ending five years following article publication for researchers who provide a methodologically sound proposal.}, URL = {https://www.medrxiv.org/content/early/2020/06/09/2020.06.08.20122531}, eprint = {https://www.medrxiv.org/content/early/2020/06/09/2020.06.08.20122531.full.pdf}, journal = {medRxiv} }